Concentra Group Holdings Parent Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Concentra Group Holdings Parent Inc in the third quarter 2026?
Concentra Group Holdings Parent Inc achieved a return on average equity (ROE) of 48.38 % in its third quarter 2026, this is above CON's average return on equity of 42.1%.
Concentra Group Holdings Parent Inc shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $458 million

While the company's net income was fading, Concentra Group Holdings Parent Inc was able to improve its ROE compared to the second quarter 2026.

Within the Healthcare Facilities industry only one company had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 207, from total ROE ranking in the second quarter 2026 at 214.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	31.76 %	39.36 %	38.33 %	42.86 %	-
Y / Y Net Income Change	32.24 %	45.69 %	28.66 %	58.73 %	8.88 %
Net Income (TTM) in Millions	222	206	184	173	159
Return On Equity (TTM)	48.38 %	48.13 %	46.95 %	47.62 %	47.9 %
CON's Total Ranking	# 207	# 214	# 104	# 112	#
Equity (TTM) in Millions	515	485	432	401	391
Seq. Equity Change	6.2 %	12.15 %	7.78 %	2.65 %	12.32 %
Seq. Net Income Change	-2.1 %	28.7 %	44.49 %	-27.36 %	7.85 %

Back to CON Management Effectiveness >> CON's 5 Years Annual ROE >> Compare CON ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 2
Sector	# 37
Overall	# 207

Return On Equity Statistics
High	Average	Low
50.78 %	42.1 %	22.79 %
(Jun 30 2025)		(Dec 31 2024)

CON Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Equity in Millions	401	281	0	0	0
Y / Y Equity Change	42.86 %	-	-	-	-
Net Income in Millions	173	172	0	0	0
Y / Y Net Income Change	0.55 %	-	-	-	-
Return On Equity	43.1 %	61.24 %	-	-	-

Back to CON Management Effectiveness >> CON's 5 Years Annual ROE >> Compare CON ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 43.1 %, despite net income growth.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CON's' Return on Equity at Yahoo Finance
CON's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CON's Competitors
Subscribers only: Roe for Concentra Group Holdings Parent Inc 's Suppliers
Subscribers only: Return On Equity for CON's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Alector Inc	112.21 %
Medpace Holdings Inc	99.76 %
3m Company	93.07 %
Exelixis Inc	85.83 %
Eli Lilly And Company	83.65 %
Rigel Pharmaceuticals Inc	73.94 %
Idexx Laboratories Inc	71.18 %
Tenet Healthcare Corp	57.13 %
Aurinia Pharmaceuticals Inc	51.92 %
Nurix Therapeutics Inc	49.34 %
Carlisle Companies Incorporated	44.18 %
Bristol myers Squibb Company	43.83 %
Zevra Therapeutics Inc	38.02 %
Dexcom Inc	36.56 %
Rallybio Corporation	36.35 %
Caredx Inc	34.08 %
Chemed Corporation	32.10 %
Illumina Inc	31.45 %
Transmedics Group Inc	28.74 %
Acadia Pharmaceuticals Inc	28.03 %
Pro dex Inc	26.91 %
Sotera Health Company	26.41 %
Pacs Group Inc	25.65 %
Standard Biotools Inc	25.58 %
Resmed Inc	25.50 %
Bioventus Inc	24.60 %
Encompass Health Corporation	24.08 %
Iradimed Corporation	23.90 %
Corcept Therapeutics Inc	22.88 %
Msa Safety Inc	21.79 %

Date modified: 2026-11-08T13:46:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.